当前位置: X-MOL 学术Leukemia › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
RSK2 is a new Pim2 target with pro-survival functions in FLT3-ITD-positive acute myeloid leukemia
Leukemia ( IF 12.8 ) Pub Date :  , DOI: 10.1038/leu.2017.284
M-A Hospital , A Jacquel , F Mazed , E Saland , C Larrue , J Mondesir , R Birsen , A S Green , M Lambert , P Sujobert , E-F Gautier , V Salnot , M Le Gall , J Decroocq , L Poulain , N Jacque , M Fontenay , O Kosmider , C Récher , P Auberger , P Mayeux , D Bouscary , J-E Sarry , J Tamburini

RSK2 is a new Pim2 target with pro-survival functions in FLT3-ITD-positive acute myeloid leukemia

Leukemia, Published online: 15 September 2017; doi:10.1038/leu.2017.284



中文翻译:

RSK2是一种新的Pim2靶标,在FLT3-ITD阳性急性髓细胞性白血病中具有促存活功能

RSK2是一种新的Pim2靶标,在FLT3-ITD阳性急性髓细胞性白血病中具有促存活功能

白血病,在线发布:2017年9月15日; doi:10.1038 / leu.2017.284

更新日期:2017-09-15
down
wechat
bug